Dal-Hee Min, Lemonex – Innovative DDS DegradaBALL | LSI Asia '25

Lemonex is a clinical-stage biotechnology company developing thermostable RNA vaccines and gene therapeutics using its proprietary DegradaBALL® drug delivery system. DegradaBALL® is a non-viral, porous nanoparticle platform that enables room-temperature storage and reduces systemic side effects compared to conventional lipid nanoparticles. Lemonex’s technology aims to broaden global access to RNA medicines by improving stability, safety, and ease of administration.